Prognostic significance of natural products against multidrug tumor resistance

被引:17
作者
Garg, Pankaj [1 ]
Garg, Rachana [2 ,3 ]
Horne, David [3 ,4 ]
Awasthi, Sanjay [5 ]
Salgia, Ravi [3 ,6 ]
Singhal, Sharad S. [3 ,6 ]
机构
[1] GLA Univ, Dept Chem, Mathura 281406, Uttar Pradesh, India
[2] Beckman Res Inst City Hope, Comprehens Canc Ctr, Dept Surg, Duarte, CA 91010 USA
[3] Natl Med Ctr, Duarte, CA 91010 USA
[4] Beckman Res Inst City Hope, Comprehens Canc Ctr, Dept Mol Med, Duarte, CA 91010 USA
[5] CTMH Doctors Hosp, Cayman Hlth, KY1-1104, George Town, Grand Cayman, Cayman Islands
[6] Beckman Res Inst City Hope, Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
基金
美国国家卫生研究院;
关键词
Chemoprevention; Natural products; Chemotherapeutic drugs; Drug resistance; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; HUMAN OVARIAN-CANCER; PROSTATE-CANCER; DIALLYL TRISULFIDE; COLON-CANCER; CYCLE ARREST; IN-VITRO; INDUCED APOPTOSIS; GENE-EXPRESSION;
D O I
10.1016/j.canlet.2023.216079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is a pervasive, constantly evolving, and significant public health concern. The number of new cancer cases has risen dramatically in the last decades, making it one of the top causes of poor health and mortality worldwide. Although various treatment strategies, including surgery, radiation, and pharmaceutical therapies, have evolved into more sophisticated, precise methods, there is not much improvement in the cancer-related death toll. Consequently, natural product-based therapeutic discoveries have recently been considered an alternative approach. According to an estimate, one-third of the top twenty medications in today's market have a natural plant-product-based origin. Accordingly, primary prevention is an essential component of worldwide cancer control. This review provides an overview of the mechanisms of action of bioactive ingredients in natural dietary products that may contribute to the prevention and management of multiple malignancies.
引用
收藏
页数:16
相关论文
共 158 条
[1]   Molecular targets of dietary agents for prevention and therapy of cancer [J].
Aggarwal, BB ;
Shishodia, S .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) :1397-1421
[2]  
Ahmad Rizwan, 2016, Biochem Pharmacol (Los Angel), V5, DOI 10.4172/2167-0501.1000202
[3]   Diallyl Disulfide-Induced Apoptosis in a Breast-Cancer Cell Line (MCF-7) May Be Caused by Inhibition of Histone Deacetylation [J].
Altonsy, Mohammed O. ;
Habib, Tito N. ;
Andrews, Simon C. .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2012, 64 (08) :1251-1260
[4]  
Ansari JA, 2016, INDIAN J EXP BIOL, V54, P767
[5]   c-Jun NH2-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells [J].
Antosiewicz, Jedrzej ;
Herman-Antosiewicz, Anna ;
Marynowski, Stanley W. ;
Singh, Shivendra V. .
CANCER RESEARCH, 2006, 66 (10) :5379-5386
[6]   Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma [J].
Appel, Elena ;
Rabinkov, Aharon ;
Neeman, Michal ;
Kohen, Fortune ;
Mirelman, David .
JOURNAL OF DRUG TARGETING, 2011, 19 (05) :326-335
[7]   Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells [J].
Arafa, El-Shaimaa A. ;
Zhu, Qianzheng ;
Shah, Zubair I. ;
Wani, Gulzar ;
Barakat, Bassant M. ;
Racoma, Ira ;
El-Mandy, Mohamed A. ;
Wani, Altar A. .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2011, 706 (1-2) :28-35
[8]   Oral Intake of Ginger for Chemotherapy-Induced Nausea and Vomiting Among Women With Breast Cancer [J].
Arslan, Muzeyyen ;
Ozdemir, Leyla .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (05) :E92-E97
[9]   Garlic compound, diallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3 [J].
Arunkumar, Arumugam ;
Vijayababu, Marati Radhakrishnan ;
Srinivasan, Narasimman ;
Aruldhas, Maria Michael ;
Arunakaran, Jagadeesan .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 288 (1-2) :107-113
[10]  
Awasthi Sanjay, 2018, Oncotarget, V9, P36202, DOI 10.18632/oncotarget.26329